[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![CorleoneDon77 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1577382889104318472.png) DonCorleone77 [@CorleoneDon77](/creator/twitter/CorleoneDon77) on x 5287 followers
Created: 2025-05-20 11:33:13 UTC

$TRML Tourmaline Bio announces results from ongoing Phase X TRANQUILITY trial

Tourmaline Bio announced positive topline results from its ongoing Phase X TRANQUILITY trial evaluating quarterly and monthly subcutaneous dosing of pacibekitug in patients with elevated high-sensitivity C-reactive protein (hs-CRP), a biomarker associated with elevated cardiovascular risk, and chronic kidney disease. The TRANQUILITY trial is the starting point of Tourmaline's clinical development program for pacibekitug for the potential treatment of atherosclerotic cardiovascular disease and other cardiovascular diseases.

Tourmaline continues to make progress in advancing the clinical development strategy for pacibekitug in cardiovascular inflammation and assessing potential Phase X trial designs in patients with ASCVD. Additionally, Tourmaline plans to initiate a Phase X proof-of-concept trial in patients with abdominal aortic aneurysm in the second half of 2025.


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1924790511115894923/c:line.svg)

**Related Topics**
[$trml](/topic/$trml)

[Post Link](https://x.com/CorleoneDon77/status/1924790511115894923)